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Abstract
Refractory dysphasia could be the main symptom of Antisynthetase syndrome
(ASS). IVIG may have a major impact in the successful treatment of dysphasia in
patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable
treatment option, and the patient regains her ability to swallow within 2 days.
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BAC KG ROU N D

Antisynthetase syndrome (ASS) is a rare inflammatory
muscle disease (2–3 times more common in women than
in men), related to dermatomyositis (DM) and polymyositis
(PM).1 The hallmark of ASS is the presence of serum autoantibodies directed against aminoacyl-tRNA synthetases
(anti-ARS involved in protein synthesis).2 including anti-Jo-,
anti-PL-12, and other antisynthetase antibodies (ASAb).1
Antisynthetase syndrome is often misdiagnosed as idiopathic Inflammatory Lung Disease (ILD) or inflammatory myopathy not only due to the lack of awareness of
the disease entity but also due to the lack of facilities for
detection of anti-ARS antibodies.3
Dysphagia is a known complication of ASS and DM
and has been reported in 18–20% of patients. We present a case of a young female with rapidly progressive
dysphagia secondary to inflammatory myopathy treated
with IVIG.
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C ASE PRESENTATION

A 33-year-old woman presented with 6-month history
of pruritic skin rashes, fevers, malaise, and 70-pounds
weight-loss. Past medical history only included well controlled asthma. Family history was remarkable for SLE
and scleroderma in two paternal cousins and leukemia in
her grandfather. Extensive infectious workup was done in
the past and she had received multiple courses of systemic
antibiotic with no improvement.
On physical examination, she had bibasilar fine crackles in the lung bases. Her skin was remarkable for erythematous scaling papules located on the lateral aspect of most
of her digit (Image A), psoriasiform raised skin lesions
on both elbows (Image B), hyperkeratotic erythematous-
flat papules on the dorsum of the metacarpophalangeal
and interphalangeal joints (Image C) and maculopapular
rash on her eyelids. Muscle strength was 4/5 in upper and
lower extremities.
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Laboratory studies showed elevated levels of ESR (63),
CRP (3.140), ferritin (182), aldolase (12.3), but a normal
CK. Given concerns for an underlying autoimmune condition, expedited rheumatologic workup was obtained
and revealed positive cardiolipin, Anti-
SSA, and Anti-
PL-12 antibodies. She had negative antibodies to PL-7, EJ,
OJ, Jo-1, Anti-smith, centromere, RNP, Scl-70, MPO, SSB,
and SRP antibodies. Her Coomb's test was positive, along
with an elevated PTT (36.3), but her remaining labs did
not show evidence of active hemolysis. A skin biopsy was
inconclusive but had findings that favored prurigo nodularis with evidence of perforation and atopic dermatitis.
Although a skin biopsy is usually not required to make a
diagnosis of DM, it can be helpful in distinguishing the
rash of DM from other conditions that can mimic DM,
such as eczema or psoriasis. We initiated glucocorticoid
therapy, resulting in significant improvement of rash. She
was discharged with oral prednisone 40 mg daily.
One month later, the patient returned with severe dysphagia, myalgias, and dyspnea. Now, her laboratory tests
showed an elevated CK (4662), and ALT/AST (183/313).
A deltoid muscle biopsy showed inflammatory myopathy
consistent with dermatomyositis. A CT Thorax was preformed to assess her dyspnea, and this revealed interstitial
fibrosis. To evaluate her dysphagia, she underwent a modified barium swallow study (MBSS) revealed an inability
to swallow both solids and liquids.
Given the constellation of findings (ILD, arthritis,
rashes, inflammatory myopathy, and anti-PL12-antibody),
our patient was diagnosed with Antisynthetase syndrome.
We escalated her therapy to intravenous SoluMedrol followed by prednisone, azathioprine, and hydroxychloroquine. This resulted in a resolution of her myalgias and an
improvement of her CK to 800. However, there were no
improvements in her dysphagia. A repeat MBSS was unchanged. Given concerns for a prolonged recovery period
for our patient's dysphagia, we discussed potential for the
need for a PEG tube. Before we proceeded with this plan,
previous case reports in DM have shown improvement of
dysphagia following months from being treated successfully with intravenous immunoglobulin. We administered
a 2-day trial of IVIG (1 g/kg per day), to which our patient
felt rapid improvement in swallowing and a repeat MBSS
in 2 days, revealed successful passage of solids and liquids.
Because inflammatory muscle diseases can occur in
association with underlying malignancy, we performed
malignancy screening tests including CT chest/abdomen/
pelvis and mammography. Screening for breast, colorectal, stomach, pancreatic, NHL, lung, and ovarian cancer
was negative. Malignancy can also be detected within
12 months following diagnosis; thus, the screening tests
were repeated in 1 year. Cancer screening was again
negative.

3 | DISC USSION AND
CONC LUSION
In recent years, Antisynthetase syndrome has increasingly been recognized as an important cause of autoimmune inflammatory myopathy in a subset of patients with
polymyositis and dermatomyositis,4 but the understanding of its treatment options is still advancing.
The three major clinical criteria for the diagnosis of
ASS include ILD, myositis, and arthritis. Presence of any
one major criterion is sufficient to make the diagnosis of
ASS. Minor criteria for the diagnosis of ASS include the
presence of mechanic's hands, Raynaud's phenomenon
and fever. The presence of “mechanic's hands” together
with diverse skin lesions could be a clinical clue to the diagnosis of lung involvement with collagen vascular diseases, especially in antisynthetase syndrome.5 Interstitial
lung disease can affect 35–40% of patients and is often associated with the presence of an antisynthetase antibody.4
Dysphagia is a serious symptom and at times presenting
problem in patients with inflammatory myopathy. It may
underlie the increased incidence of bacterial pneumonia,
and nutritional deficit.
Whether the diagnosis of ASS can be made solely based
on minor criteria is not clear. However, the obligatory criterion for the diagnosis of ASS remains the demonstration
of anti-ARS antibodies in the serum.3
While initial therapy should be started with prednisone and azathioprine, treatment options for refractory
cases remain unclear. Other immunosuppressants and
immunomodulatory therapies have been used for steroid-
refractory cases.3 In 2006, a case report showed that treatment with rituximab according to the protocol used in
rheumatoid arthritis resulted in a rapid resolution of myositis and other inflammatory features of Antisynthetase
syndrome.2
There are limited amount of literature discussing the
potential use of IVIG.6 In 1993, a double blinded trial with
15 patients showed the benefit of once-a-month IVIG for
3 months in the treatment of refractory dermatomyositis.7
A more recent case in 2018, a 53-year-old Korean male
with dermatomyositis and severe dysphagia had significant improvement at 2 months from the IVIG therapy.8
To our knowledge, high-dose IVIG and cyclophosphamide have been effective in a few cases of steroid-resistant
dysphagia. However, there was no immediate improvement of dysphagia reported.3
Our case demonstrates the potential benefits of IVIG
as a form of treatment for the disease. Limited literature
has discussed the potential of IVIG, but our case specifically demonstrates drastic and rapid improvement of severe dysphagia in this setting. The administration of IVIG
could be costly and requires close monitoring, but it may
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prove to have significant benefits that outweigh the risks
and costs for patients.6
IVIG is also safer and could be better tolerated than
corticosteroids or the other immunosuppressive medications and, despite the cost, may be considered the first-line
drug for use as a steroid-sparing agent.7
We believe that further investigation of the treatment of dysphagia and other clinical manifestations of
Antisynthetase Syndrome with IVIG is well warranted.
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B) Psoriasiform raised skin lesions on elbows.

C) Gottron's papules: Violaceous, scaling papules on the
skin overlying the joints.

A) Mechanic hands: Erythematous, scaling papules located on the lateral aspect of the second and third digits.
Overgrown cuticles are seen containing multiple petite
hemorrhages.
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